X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Treatment of Mild to Moderate COVID-19

    Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

    Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

    Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

    Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

    Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Covance launches COVID-19 clinical trial matching platform

    Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

    Johnson & Johnson moves up COVID-19 vaccine trial to second half of July

    Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

    Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

    Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

    Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

    Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina

    Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Treatment of Mild to Moderate COVID-19

    Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

    Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

    Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

    Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

    Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Covance launches COVID-19 clinical trial matching platform

    Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

    Johnson & Johnson moves up COVID-19 vaccine trial to second half of July

    Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

    Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

    Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

    Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

    Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina

    Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

The Future Healthcare Challenge Turkey meets you with an extraordinary fair in Istanbul

Content Team by Content Team
10th August 2019
in Middle East and South Asia, Press Statements
The Future Healthcare Challenge Turkey meets you with an extraordinary fair in Istanbul

The Future Healthcare Turkey 2019 is the most ambitious meeting point of the region, you may introduce your advanced healthcare solutions and technologies to VIP BUYERS in this rapidly increasing sector and can express yourself in panels.

During The Future Healthcare Turkey 2019 you can reach all kinds of high quality products, suppliers, investors, customers, decision makers related to healthcare; perform purchases, sales and agreements.

Previous Post

Arena Reports Second Quarter Financial Results with Strong Liquidity Position and Olorinab CAPTIVATE Trials

 Next Post

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

Related Posts

Treatment of Mild to Moderate COVID-19
Drug Development

Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

22nd June 2020
Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19
Clinical Trials

Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

16th June 2020
Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre
Drug Development

Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

15th June 2020
EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
Clinical Trials

Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

15th June 2020
Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe
FDA Approvals

Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

15th June 2020
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility
Manufacturing

Valor Glass Packaging Selected to Accelerate Delivery of COVID-19 Vaccines

15th June 2020
Next Post
Dynacure DYN101

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

Latest News

Treatment of Mild to Moderate COVID-19
Drug Development

Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

22nd June 2020
Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19
Clinical Trials

Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

16th June 2020
Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre
Drug Development

Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

15th June 2020
EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
Clinical Trials

Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

15th June 2020
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Covance launches COVID-19 clinical trial matching platform

15th June 2020
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In